Drug Patent Expirations for the Week of April 28, 2024

MYRBETRIQ GRANULES (mirabegron) Apgdi Patent: 7,982,049 Expiration: May 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…

Source


Comments are closed.

Biotechblog